Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-18

Clinical Trial Update: Oral Propionate to Treat and Prevent Diabetes [NA]

View source ↗

Summary

A clinical trial evaluating oral propionate to treat and prevent diabetes sponsored by Imperial College London was terminated, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Propionate

Snippet

Sponsor: Imperial College London | Conditions: Diabetes Mellitus | NA | Status: TERMINATED | Results posted: 2025-06-18